A Study of MHB088C Combined With MHB039A in Patients With Advanced Malignant Solid Tumors

Clinical trial NCT07126665 · RECRUITING

Trial details

NCT number: NCT07126665
Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Malignant Solid Tumor

Start date: 2025-09-18
Primary completion: 2029-08-01
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.